Clinical and Immunologic Correlates of Vasodilatory Shock Among Ebola Virus–Infected Nonhuman Primates in a Critical Care Model

Abstract Background Existing models of Ebola virus infection have not fully characterized the pathophysiology of shock in connection with daily virologic, clinical, and immunologic parameters. We implemented a nonhuman primate critical care model to investigate these associations. Methods Two rhesus...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 228; no. Supplement_7; pp. S635 - S647
Main Authors Stein, Sydney R, Platt, Andrew P, Teague, Heather L, Anthony, Scott M, Reeder, Rebecca J, Cooper, Kurt, Byrum, Russell, Drawbaugh, David J, Liu, David X, Burdette, Tracey L, Hadley, Kyra, Barr, Bobbi, Warner, Seth, Rodriguez-Hernandez, Francisco, Johnson, Cristal, Stanek, Phil, Hischak, Joseph, Kendall, Heather, Huzella, Louis M, Strich, Jeffrey R, Herbert, Richard, St. Claire, Marisa, Vannella, Kevin M, Holbrook, Michael R, Chertow, Daniel S
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 15.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Existing models of Ebola virus infection have not fully characterized the pathophysiology of shock in connection with daily virologic, clinical, and immunologic parameters. We implemented a nonhuman primate critical care model to investigate these associations. Methods Two rhesus macaques received a target dose of 1000 plaque-forming units of Ebola virus intramuscularly with supportive care initiated on day 3. High-dimensional spectral cytometry was used to phenotype neutrophils and peripheral blood mononuclear cells daily. Results We observed progressive vasodilatory shock with preserved cardiac function following viremia onset on day 5. Multiorgan dysfunction began on day 6 coincident with the nadir of circulating neutrophils. Consumptive coagulopathy and anemia occurred on days 7 to 8 along with irreversible shock, followed by death. The monocyte repertoire began shifting on day 4 with a decline in classical and expansion of double-negative monocytes. A selective loss of CXCR3-positive B and T cells, expansion of naive B cells, and activation of natural killer cells followed viremia onset. Conclusions Our model allows for high-fidelity characterization of the pathophysiology of acute Ebola virus infection with host innate and adaptive immune responses, which may advance host-targeted therapy design and evaluation for use after the onset of multiorgan failure.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jiad374